Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the

Joseph G Pressey1, James R Anderson, David K Crossman

  • 1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. jpressey@uab.edu

Abstract

Insights

Aberrant hedgehog (Hh) signaling is active in some pediatric rhabdomyosarcoma (RMS) and undifferentiated sarcoma (US) tumors. This pathway may be a new therapeutic target for these cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Aberrant activation of the hedgehog (Hh) signaling pathway is implicated in numerous pediatric and adult malignancies.
  • Inactivation of the Hh regulator PTCH causes Gorlin syndrome, a cancer predisposition syndrome.
  • Hh pathway targets GLI1 and PTCH have shown initial evidence of expression in rhabdomyosarcoma (RMS) tumors.

Purpose of the Study:

  • To investigate the role of Hh pathway signaling in pediatric RMS and undifferentiated sarcoma (US) tumors.
  • To measure the expression of Hh pathway targets GLI1 and PTCH in these pediatric tumors.

Main Methods:

  • RNA extraction from archival human tumor specimens from pediatric patients.
  • Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) to measure GLI1 and PTCH expression.
  • Microarray analysis to assess downstream Hh target gene expression.

Main Results:

  • GLI1 and/or PTCH expression was detected in significant subsets of embryonal RMS (ERMS) and US tumors, but rarely in alveolar RMS.
  • No PTCH or SMO mutations were found in ERMS tumors with high GLI1 expression.
  • Microarray analysis revealed overexpression of downstream Hh targets in ERMS tumors with high or intermediate GLI1 expression.

Conclusions:

  • Findings support a role for Hh pathway activation in the development of a subset of ERMS and US tumors.
  • Hedgehog signaling represents a potential novel therapeutic target for these specific pediatric sarcomas.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...